• Dry Cracked Skin
  • General Dermatology
  • Impetigo
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The Weekly Roundup: February 5-9


ICYMI, this week we had news about Masterclasses in Dermatology, JNJ-2113's significant PASI and IGA responses for plaque psoriasis, Almirall's partnership with the Centre for Genomic Regulation, and more.

Derm In The News: January 28-February 3

Keep up with the latest headlines in dermatology from the past week, including the role of the US in hosting more than half of the world's skin cancer-related trials, new AAD guidelines for acne, and more.

Imbed Biosciences Receives Technology Breakthrough Designation for PelashieldAM from Premier, Inc

The Technology Breakthrough designation will enable health care providers to access exclusive pricing and terms for the solution in pediatric burn care.

Mediating Factors in Secondhand Smoke and Atopic Dermatitis in Adolescents

Investigators highlighted the importance of considering household second hand smoke exposure when evaluating adolescents with AD.

The American Skin Association Announces 2024 Funding Opportunities for Dermatology Researchers

The submission deadline for this year’s awards and grants is Friday, March 15, 2024. Award recipients will be notified in June 2024, and the grant period for all awards is 1 year beginning on July 1, 2024.

Countdown to Masterclasses in Dermatology

The conference's course directors give a sneak peek of what in-person and virtual attendees will learn about AI, alternative medicine, surgical management of HS, and more.

Enhancing Your Toolbox to Improve Patient Care

This year is already off to a busy start, and Dermatology Times is prepared to provide our readers with the most up-to-date clinical content from innovative studies and FDA approvals to exclusive interviews and expert insights.

Dupilumab With Topical Corticosteroids Alleviates Clinical Symptoms of Pediatric Atopic Dermatitis

Researchers explored the efficacy of a multistep treatment strategy in a younger patient population.

Icahn School of Medicine Partners With Clinique, Establishing the Mount Sinai-Clinique Healthy Skin Dermatology Center

The partnership and newly-established center will develop dermatological research and delve into skin aging, skin allergies, and inflammatory or eczematous conditions.

Exploring the Emergence of Genomic Testing in Dermatology

A team of dermatology physician assistants recently reviewed the current and future potential of genomic testing in the realm of dermatology.

What Constitutes an AD Flare? A Patient Perspective

Atopic dermatitis flares are about more than just skin symptoms and are difficult to quantify, according to a study that asked patients to describe them.

Launching Into Space: Is Dermatology Ready?

Star Trek may call space “the final frontier,” but it’s really the next exciting frontier for humans. For now, we can learn about the various new innovations and therapies for skin disease at the AAD annual meeting—and continue to strive to improve our patients’ lives here on Earth.

Decentralized Clinical Trials May Address Gender Bias, Inclusivity of Clinical Trials

Decentralized clinical trials (are emerging as a crucial avenue for transforming this gender bias and fostering inclusivity within health care research.

Clothianidin Exposure Suppresses Early Symptoms of AD in Mouse Model Study

Exposure led to an increase in total plasma IgE levels but reduced epidermal thickening, mast cell number, and plasma histamine levels in the early stages of AD.

FDA To Permit Using 3 Tubes of Actinic Keratosis Drug Per Treatment

An increased number of tubes of aminolevulinic acid hydrochloride 10% will help patients who have actinic keratosis over large surface areas.

What to Recommend for OTC Acne-Prone Skin Care

There’s nothing worse than having OTC products fight back against the progress we make with our prescription therapies.

Targeted Oral Peptide JNJ-2113 Led to Significant PASI, IGA Responses in Phase 2b Trial for Plaque Psoriasis

Data from the FRONTIER 1 clinical trial were recently published in the New England Journal of Medicine.

NEJM Publishes Data on the Application of B-VEC to Treat Ocular Complications in Patients with DEB

Krystal Biotech’s B-VEC was administered as an eyedrop for a patient with dystrophic epidermolysis bullosa with cicatrizing conjunctivitis.

Physician Assistant Profession Ranks 5th in List of 100 Best Jobs

For the third consecutive year, physician assistants ranked number 2 behind nurse practitioners in the individual healthcare sector listing.

Almirall, Centre for Genomic Regulation Partner to Identify Molecular Pathways and Biomarkers for Atopic Dermatitis Treatments

The partnership is focused on exploring innovative therapeutic strategies to address AD.

Biologic Therapies: Innovative Treatments Confront Real-World Challenges

Biologics represent the pinnacle of scientific progress, engineered to precisely target conditions previously deemed untreatable. However, any dermatology provider who has prescribed one quickly learns of the immense barriers surrounding them.

Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.

Communication Is Key in Atopic Dermatitis Treatment

A discussion among roundtable participants revolved around the importance of effective communication, the impact of prolonged use of topical steroids, and the need for trust building in recommending novel treatment options.

IGA, EASI, and Itch Endpoints Met in First In Human Phase 2 Trial of Zabalafin for Atopic Dermatitis

Interim data from the clinical trial was presented in a poster at the South Beach Symposium, with itch reduction demonstrating immediacy and long-term capability.

QUIZ: What Should a Patient With Vitiligo Avoid When Concerned About Flares?

For a patient with vitiligo who is concerned about potential flares, what might you recommend avoiding?

Topical Sulfur Cream 2.0% Demonstrates Equal Efficacy in Hand Eczema as Triamcinolone 0.1% Cream

Both cream options were capable of reducing scores of itching, drying, burning, redness, and more.

Gaining Access to Roflumilast Foam and Cabtreo in 2024

Shanna Miranti, MPAS, PA-C, shares updates on the status of roflumilast foam 0.3% and Cabtreo available in US pharmacies.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.